These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 26955632)
1. Macrophage Infiltration into the Glomeruli in Lipoprotein Glomerulopathy. Takasaki S; Maeda K; Joh K; Yamakage S; Fukase S; Takahashi T; Suzuki M; Matsunaga A; Saito T Case Rep Nephrol Dial; 2015; 5(3):204-12. PubMed ID: 26955632 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E-related glomerular disorders. Saito T; Matsunaga A; Fukunaga M; Nagahama K; Hara S; Muso E Kidney Int; 2020 Feb; 97(2):279-288. PubMed ID: 31874799 [TBL] [Abstract][Full Text] [Related]
3. A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I. Takasaki S; Matsunaga A; Joh K; Saito T CEN Case Rep; 2018 May; 7(1):127-131. PubMed ID: 29356944 [TBL] [Abstract][Full Text] [Related]
4. A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy. Tokura T; Itano S; Kobayashi S; Kuwabara A; Fujimoto S; Horike H; Satoh M; Komai N; Tomita N; Matsunaga A; Saito T; Sasaki T; Kashihara N J Atheroscler Thromb; 2011; 18(6):536-41. PubMed ID: 21467726 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein Glomerulopathy, First Case Report from Canada. Ting JA; McRae SA; Schwartz D; Barbour SJ; Riazy M Int J Nephrol Renovasc Dis; 2022; 15():207-214. PubMed ID: 35761986 [TBL] [Abstract][Full Text] [Related]
6. Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy. Hoffmann MM; Scharnagl H; Panagiotou E; Banghard WT; Wieland H; März W J Am Soc Nephrol; 2001 Mar; 12(3):524-530. PubMed ID: 11181800 [TBL] [Abstract][Full Text] [Related]
7. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Saito T; Matsunaga A; Oikawa S Am J Kidney Dis; 2006 Feb; 47(2):199-211. PubMed ID: 16431249 [TBL] [Abstract][Full Text] [Related]
8. Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America. da Silveira-Neto JN; de Oliveira Ahn GJ; de Menezes Neves PDM; Baptista VAF; de Almeida Araújo S; Wanderley DC; Watanabe A; Watanabe EH; Murai NM; Bertollo EMG; Vieira-Neto OM; Dantas M; de Antônio SR; Costa RS; Baptista MASF; Moysés-Neto M; Onuchic LF Diagn Pathol; 2021 Jul; 16(1):65. PubMed ID: 34311745 [TBL] [Abstract][Full Text] [Related]
9. A case of apolipoprotein E Toyonaka and homozygous apolipoprotein E2/2 showing non-immune membranous nephropathy-like glomerular lesions with foamy changes. Kato T; Ushiogi Y; Yokoyama H; Hara S; Matsunaga A; Muso E; Saito T CEN Case Rep; 2019 May; 8(2):106-111. PubMed ID: 30701487 [TBL] [Abstract][Full Text] [Related]
10. A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate. Kodera H; Mizutani Y; Sugiyama S; Miyata T; Ehara T; Matsunaga A; Saito T Case Rep Nephrol Dial; 2017; 7(2):112-120. PubMed ID: 28966924 [TBL] [Abstract][Full Text] [Related]
11. An Updated Review and Meta Analysis of Lipoprotein Glomerulopathy. Li MS; Li Y; Liu Y; Zhou XJ; Zhang H Front Med (Lausanne); 2022; 9():905007. PubMed ID: 35602473 [TBL] [Abstract][Full Text] [Related]
12. Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report. Cautero N; Di Benedetto F; De Ruvo N; Montalti R; Guerrini GP; Ballarin R; Spaggiari M; Smerieri N; De Blasiis MG; Rompianesi G; Iemmolo RM; Marino M; Bertolotti M; Zivieri S; Gerunda GE Transplant Proc; 2010 May; 42(4):1349-51. PubMed ID: 20534298 [TBL] [Abstract][Full Text] [Related]
13. A case of nephrotic syndrome showing contemporary presence of apolipoprotein E2 homozygote glomerulopathy and membranous nephropathy-like findings modified by apolipoprotein E Toyonaka. Hirashima H; Komiya T; Toriu N; Hara S; Matsunaga A; Saito T; Muso E Clin Nephrol Case Stud; 2018; 6():45-51. PubMed ID: 30542638 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy. Qin Y; Sun XJ; Hu YF; Jing M; Yu XJ; Zhao MH; Tan Y Ren Fail; 2024 Dec; 46(1):2332491. PubMed ID: 38584145 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3. Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707 [TBL] [Abstract][Full Text] [Related]
16. Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features. Saito T; Oikawa S; Sato H; Sato T; Ito S; Sasaki J Kidney Int Suppl; 1999 Jul; 71():S37-41. PubMed ID: 10412734 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report. Kato J; Okonogi H; Kanzaki G; Katsumata H; Nakada Y; Sagasaki M; Komine K; Ito K; Saito T; Matsunaga A; Tokutou K; Honda K; Tsuboi N; Yokoo T BMC Nephrol; 2024 May; 25(1):171. PubMed ID: 38769490 [TBL] [Abstract][Full Text] [Related]
19. Glomerulopathy with homozygous apolipoprotein e2: a report of three cases and review of the literature. Kawanishi K; Sawada A; Ochi A; Moriyama T; Mitobe M; Mochizuki T; Honda K; Oda H; Nishikawa T; Nitta K Case Rep Nephrol Urol; 2013 Jul; 3(2):128-35. PubMed ID: 24570682 [TBL] [Abstract][Full Text] [Related]
20. A young Chinese man with nephrotic syndrome due to lipoprotein glomerulopathy. Lui DTW; Lee ACH; Yap DYH; Chan GSW; Tan KCB J Clin Lipidol; 2019; 13(2):251-253. PubMed ID: 30685233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]